Intech Biopharm Corporation announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 4.170 million compared to TWD 6.455 million a year ago. Operating loss was TWD 79.758 million compared to TWD 57.277 million a year ago. Net loss was TWD 82.273 million compared to TWD 59.672 million a year ago. Basic loss per share was TWD 0.82 compared to TWD 0.6 a year ago. For the half year, sales was TWD 11.328 million compared to TWD 11.767 million a year ago. Operating loss was TWD 144.963 million compared to TWD 114.575 million a year ago. Net loss was TWD 150.178 million compared to TWD 119.595 million a year ago. Basic loss per share was TWD 1.5 compared to TWD 1.19 a year ago.